# Hydrofarm Holdings Group, Inc.: financial statements, quarterly

HYFM · Nasdaq · CIK 1695295 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hyfm.md) · [Financials](/companies/hyfm/financials.md) · [Filings](/companies/hyfm/filings.md) · [Insiders](/companies/hyfm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hyfm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [54.2](/filings/0001628280-24-046008.md) | [47.2 d](/filings/0001628280-25-010266.md) | [54.2](/filings/0001628280-25-024915.md) | [54.8](/filings/0001628280-25-039772.md) | [44.0](/filings/0001695295-25-000010.md) | [37.3 d](/filings/0001695295-26-000010.md) | [40.5](/filings/0001628280-25-024915.md) | [39.2](/filings/0001628280-25-039772.md) | [29.4](/filings/0001695295-25-000010.md) | [25.1 d](/filings/0001695295-26-000010.md) | [28.5](/filings/0001437749-26-017373.md) | [23.2](/filings/0001437749-26-028012.md) |
| Cost of revenue | $m | [50.9](/filings/0001628280-24-046008.md) | [38.7 d](/filings/0001628280-25-010266.md) | [43.2](/filings/0001628280-25-024915.md) | [43.9](/filings/0001628280-25-039772.md) | [35.5](/filings/0001695295-25-000010.md) | [35.5 d](/filings/0001695295-26-000010.md) | [33.7](/filings/0001437749-26-017373.md) | [36.5](/filings/0001437749-26-028012.md) | [25.9](/filings/0001695295-25-000010.md) | [23.0 d](/filings/0001695295-26-000010.md) | [26.7](/filings/0001437749-26-017373.md) | [20.6](/filings/0001437749-26-028012.md) |
| Gross profit | $m | [3.3](/filings/0001628280-24-046008.md) | [8.4 d](/filings/0001628280-25-010266.md) | [10.9](/filings/0001628280-25-024915.md) | [10.9](/filings/0001628280-25-039772.md) | [8.5](/filings/0001695295-25-000010.md) | [1.8 d](/filings/0001695295-26-000010.md) | [6.9](/filings/0001437749-26-017373.md) | [2.8](/filings/0001437749-26-028012.md) | [3.4](/filings/0001695295-25-000010.md) | [2.1 d](/filings/0001695295-26-000010.md) | [1.8](/filings/0001437749-26-017373.md) | [2.6](/filings/0001437749-26-028012.md) |
| Selling, general and administrative | $m | [19.5](/filings/0001628280-24-046008.md) | [19.9 d](/filings/0001628280-25-010266.md) | [19.6](/filings/0001628280-25-024915.md) | [18.7](/filings/0001628280-25-039772.md) | [17.6](/filings/0001695295-25-000010.md) | [17.0 d](/filings/0001695295-26-000010.md) | [17.9](/filings/0001437749-26-017373.md) | [16.1](/filings/0001437749-26-028012.md) | [16.4](/filings/0001695295-25-000010.md) | [9.6 d](/filings/0001695295-26-000010.md) | [10.6](/filings/0001437749-26-017373.md) | [10.1](/filings/0001437749-26-028012.md) |
| Operating income | $m | [(16.2)](/filings/0001628280-24-046008.md) | [(11.4) d](/filings/0001628280-25-010266.md) | [(8.7)](/filings/0001628280-25-024915.md) | [(19.3)](/filings/0001628280-25-039772.md) | [(9.0)](/filings/0001695295-25-000010.md) | [(15.1) d](/filings/0001695295-26-000010.md) | [(11.0)](/filings/0001437749-26-017373.md) | [(13.3)](/filings/0001437749-26-028012.md) | [(13.0)](/filings/0001695295-25-000010.md) | [(240) d](/filings/0001695295-26-000010.md) | [(8.7)](/filings/0001437749-26-017373.md) | [(7.4)](/filings/0001437749-26-028012.md) |
| Interest expense | $m | [4.0](/filings/0001628280-23-038284.md) | [4.0 d](/filings/0001628280-24-007813.md) | [3.9](/filings/0001628280-24-023075.md) | [3.8](/filings/0001628280-25-039772.md) | [3.9](/filings/0001695295-25-000010.md) | [3.6 d](/filings/0001695295-26-000010.md) | [3.4](/filings/0001437749-26-017373.md) | [3.4](/filings/0001437749-26-028012.md) | [3.3](/filings/0001695295-25-000010.md) | [3.3 d](/filings/0001695295-26-000010.md) | [5.9](/filings/0001437749-26-017373.md) | [3.5](/filings/0001437749-26-028012.md) |
| Income tax | $m | [0.1](/filings/0001628280-24-046008.md) | [(0.1) d](/filings/0001628280-25-010266.md) | [0.2](/filings/0001628280-25-024915.md) | [0.4](/filings/0001628280-25-039772.md) | [0.3](/filings/0001695295-25-000010.md) | [0.0 d](/filings/0001695295-26-000010.md) | [0.1](/filings/0001437749-26-017373.md) | [(0.1)](/filings/0001437749-26-028012.md) | [0.1](/filings/0001695295-25-000010.md) | [(0.8) d](/filings/0001695295-26-000010.md) | [(0.1)](/filings/0001437749-26-017373.md) | [(0.2)](/filings/0001437749-26-028012.md) |
| Net income | $m | [(19.9)](/filings/0001628280-24-046008.md) | [(15.2) d](/filings/0001628280-25-010266.md) | [(12.6)](/filings/0001628280-25-024915.md) | [(23.5)](/filings/0001628280-25-039772.md) | [(13.1)](/filings/0001695295-25-000010.md) | [(17.5) d](/filings/0001695295-26-000010.md) | [(14.4)](/filings/0001437749-26-017373.md) | [(16.9)](/filings/0001437749-26-028012.md) | [(16.4)](/filings/0001695295-25-000010.md) | [(242) d](/filings/0001695295-26-000010.md) | [(14.6)](/filings/0001437749-26-017373.md) | [(10.6)](/filings/0001437749-26-028012.md) |
| Diluted EPS | $ per share | [(0.44)](/filings/0001628280-24-046008.md) | not reported | [(2.75)](/filings/0001628280-25-024915.md) | [(5.10)](/filings/0001628280-25-039772.md) | [(2.86)](/filings/0001695295-25-000010.md) | not reported | [(3.12)](/filings/0001437749-26-017373.md) | [(3.63)](/filings/0001437749-26-028012.md) | [(3.51)](/filings/0001695295-25-000010.md) | not reported | [(3.07)](/filings/0001437749-26-017373.md) | [(2.23)](/filings/0001437749-26-028012.md) |
| Basic EPS | $ per share | [(0.44)](/filings/0001628280-24-046008.md) | not reported | [(2.75)](/filings/0001628280-25-024915.md) | [(5.10)](/filings/0001628280-25-039772.md) | [(2.86)](/filings/0001695295-25-000010.md) | not reported | [(3.12)](/filings/0001437749-26-017373.md) | [(3.63)](/filings/0001437749-26-028012.md) | [(3.51)](/filings/0001695295-25-000010.md) | not reported | [(3.07)](/filings/0001437749-26-017373.md) | [(2.23)](/filings/0001437749-26-028012.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [32.5](/filings/0001628280-23-038284.md) | [30.3](/filings/0001628280-25-010266.md) | [24.2](/filings/0001628280-24-023075.md) | [30.3](/filings/0001628280-24-035894.md) | [24.4](/filings/0001628280-24-046008.md) | [26.1](/filings/0001695295-26-000010.md) | [13.7](/filings/0001628280-25-024915.md) | [11.0](/filings/0001628280-25-039772.md) | [10.7](/filings/0001695295-25-000010.md) | [6.3](/filings/0001437749-26-028012.md) | [4.8](/filings/0001437749-26-017373.md) | [6.2](/filings/0001437749-26-028012.md) |
| Current assets | $m | [134](/filings/0001628280-23-038284.md) | [128](/filings/0001628280-25-010266.md) | [124](/filings/0001628280-24-023075.md) | [112](/filings/0001628280-24-035894.md) | [103](/filings/0001628280-24-046008.md) | [95.2](/filings/0001695295-26-000010.md) | [88.7](/filings/0001628280-25-024915.md) | [73.0](/filings/0001628280-25-039772.md) | [62.6](/filings/0001695295-25-000010.md) | [51.4](/filings/0001437749-26-028012.md) | [50.5](/filings/0001437749-26-017373.md) | [39.9](/filings/0001437749-26-028012.md) |
| Total assets | $m | [522](/filings/0001628280-23-038284.md) | [508](/filings/0001628280-25-010266.md) | [494](/filings/0001628280-24-023075.md) | [463](/filings/0001628280-24-035894.md) | [446](/filings/0001628280-24-046008.md) | [426](/filings/0001695295-26-000010.md) | [411](/filings/0001628280-25-024915.md) | [390](/filings/0001628280-25-039772.md) | [370](/filings/0001695295-25-000010.md) | [124](/filings/0001437749-26-028012.md) | [118](/filings/0001437749-26-017373.md) | [102](/filings/0001437749-26-028012.md) |
| Current liabilities | $m | [35.4](/filings/0001628280-23-038284.md) | [37.7](/filings/0001628280-25-010266.md) | [39.3](/filings/0001628280-24-023075.md) | [35.5](/filings/0001628280-24-035894.md) | [31.9](/filings/0001628280-24-046008.md) | [35.0](/filings/0001695295-26-000010.md) | [39.9](/filings/0001628280-25-024915.md) | [31.5](/filings/0001628280-25-039772.md) | [30.1](/filings/0001695295-25-000010.md) | [140](/filings/0001437749-26-028012.md) | [151](/filings/0001437749-26-017373.md) | [148](/filings/0001437749-26-028012.md) |
| Total liabilities | $m | [219](/filings/0001628280-23-038284.md) | [217](/filings/0001628280-25-010266.md) | [216](/filings/0001628280-24-023075.md) | [208](/filings/0001628280-24-035894.md) | [203](/filings/0001628280-24-046008.md) | [202](/filings/0001695295-26-000010.md) | [201](/filings/0001628280-25-024915.md) | [195](/filings/0001628280-25-039772.md) | [191](/filings/0001695295-25-000010.md) | [187](/filings/0001437749-26-028012.md) | [196](/filings/0001437749-26-017373.md) | [191](/filings/0001437749-26-028012.md) |
| Long-term debt | $m | [117](/filings/0001628280-23-038284.md) | [115](/filings/0001628280-25-010266.md) | [115](/filings/0001628280-24-023075.md) | [115](/filings/0001628280-24-035894.md) | [115](/filings/0001628280-24-046008.md) | [115](/filings/0001695295-26-000010.md) | [110](/filings/0001628280-25-024915.md) | [112](/filings/0001628280-25-039772.md) | [112](/filings/0001695295-25-000010.md) | [0.1](/filings/0001437749-26-028012.md) | [0.0](/filings/0001437749-26-017373.md) | [0.0](/filings/0001437749-26-028012.md) |
| Current portion of debt | $m | [1.3](/filings/0001628280-23-038284.md) | [3.0](/filings/0001628280-25-010266.md) | [1.3](/filings/0001628280-24-023075.md) | [1.6](/filings/0001628280-24-035894.md) | [1.3](/filings/0001628280-24-046008.md) | [1.3](/filings/0001695295-26-000010.md) | [5.9](/filings/0001628280-25-024915.md) | [0.0](/filings/0001628280-25-039772.md) | [0.0](/filings/0001695295-25-000010.md) | [112](/filings/0001437749-26-028012.md) | [114](/filings/0001437749-26-017373.md) | [114](/filings/0001437749-26-028012.md) |
| Shareholders' equity | $m | [304](/filings/0001628280-24-046008.md) | [291](/filings/0001695295-26-000010.md) | [278](/filings/0001628280-25-039772.md) | [255](/filings/0001695295-25-000010.md) | [243](/filings/0001695295-25-000010.md) | [224](/filings/0001437749-26-028012.md) | [210](/filings/0001437749-26-028012.md) | [195](/filings/0001437749-26-028012.md) | [178](/filings/0001695295-25-000010.md) | [(63.3)](/filings/0001437749-26-028012.md) | [(78.1)](/filings/0001437749-26-028012.md) | [(89.0)](/filings/0001437749-26-028012.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [7.7 d](/filings/0001628280-24-046008.md) | [(1.6) d](/filings/0001628280-25-010266.md) | [(2.3)](/filings/0001628280-25-024915.md) | [3.8 d](/filings/0001628280-25-039772.md) | [(4.5) d](/filings/0001695295-25-000010.md) | [2.7 d](/filings/0001695295-26-000010.md) | [(11.8)](/filings/0001437749-26-017373.md) | [1.7 d](/filings/0001437749-26-028012.md) | [(0.0) d](/filings/0001695295-25-000010.md) | [(4.0) d](/filings/0001695295-26-000010.md) | [(0.8)](/filings/0001437749-26-017373.md) | [0.1 d](/filings/0001437749-26-028012.md) |
| Capital expenditure | $m | [0.8 d](/filings/0001628280-24-046008.md) | [0.2 d](/filings/0001628280-25-010266.md) | [1.4](/filings/0001628280-25-024915.md) | [0.4 d](/filings/0001628280-25-039772.md) | [0.8 d](/filings/0001695295-25-000010.md) | [0.3 d](/filings/0001695295-26-000010.md) | [0.2](/filings/0001437749-26-017373.md) | [0.3 d](/filings/0001437749-26-028012.md) | [0.2 d](/filings/0001695295-25-000010.md) | [0.3 d](/filings/0001695295-26-000010.md) | [0.0](/filings/0001437749-26-017373.md) | [0.1 d](/filings/0001437749-26-028012.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [45.1](/filings/0001628280-23-038284.md) | [45.3](/filings/0001628280-24-023075.md) | [45.4](/filings/0001628280-24-035894.md) | [45.6](/filings/0001628280-24-046008.md) | [4.6](/filings/0001628280-25-024915.md) | [4.6](/filings/0001628280-25-039772.md) | [4.6](/filings/0001695295-25-000010.md) | [4.6](/filings/0001437749-26-017373.md) | [4.6](/filings/0001437749-26-028012.md) | [4.7](/filings/0001695295-25-000010.md) | [4.8](/filings/0001437749-26-017373.md) | [4.8](/filings/0001437749-26-028012.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 4,819,323 at 2026-08-12, from the cover of the [10-Q filed 2026-08-14](/filings/0001437749-26-028012.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.